Huntington National Bank Amgen Inc Transaction History

Huntington National Bank

$13.5 Billion
Q3 2024

A detailed history of Huntington National Bank transactions in Amgen Inc stock. As of the latest transaction made, Huntington National Bank holds 49,037 shares of AMGN stock, worth $14.4 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

49,037

Previous 49,338 0.61%

Holding current value

$14.4 Million

Previous $15.4 Million 2.5%

% of portfolio

0.12%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$309.38 - $337.38 $93,123 - $101,551	-301 Reduced 0.61%	49,037 $15.8 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $53,075 - $64,500	202 Added 0.41%	49,338 $15.4 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $750,953 - $906,496	-2,793 Reduced 5.38%	49,136 $14 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $175,921 - $198,460	-688 Reduced 1.31%	51,929 $15 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $270,251 - $335,524	-1,236 Reduced 2.3%	52,617 $14.1 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $939,788 - $1.11 Million	-4,386 Reduced 7.53%	53,853 $12 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $2.21 Million - $2.7 Million	-9,804 Reduced 14.41%	58,239 $14.1 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $1.27 Million - $1.61 Million	-5,547 Reduced 7.54%	68,043 $17.9 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $872,476 - $983,994	-3,887 Reduced 5.02%	73,590 $16.6 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $237,400 - $264,185	-1,029 Reduced 1.31%	77,477 $18.8 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $672,281 - $743,719	-3,066 Reduced 3.76%	78,506 $19 Million
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $1.3 Million - $1.49 Million	-6,551 Reduced 7.43%	81,572 $18.4 Million
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $674,594 - $790,368	-3,178 Reduced 3.48%	88,123 $18.7 Million
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $2.49 Million - $2.76 Million	10,651 Added 13.21%	91,301 $22.3 Million
Q1 2021 Apr 12, 2021	SELL	$221.91 - $258.6 $831,940 - $969,491	-3,749 Reduced 4.44%	80,650 $20.1 Million
Q4 2020 Jan 11, 2021	SELL	$216.38 - $257.67 $2 Million - $2.39 Million	-9,264 Reduced 9.89%	84,399 $19.4 Million
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $403,363 - $448,573	-1,719 Reduced 1.8%	93,663 $23.8 Million
Q2 2020 Jul 30, 2020	SELL	$197.81 - $242.74 $679,081 - $833,326	-3,433 Reduced 3.47%	95,382 $22.5 Million
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $662,624 - $878,821	-3,636 Reduced 3.55%	98,815 $20 Million
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $300,087 - $385,715	-1,586 Reduced 1.52%	102,451 $24.7 Million
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $1.82 Million - $2.18 Million	-10,443 Reduced 9.12%	104,037 $20.1 Million
Q2 2019 Jul 23, 2019	SELL	$166.7 - $195.41 $1.96 Million - $2.29 Million	-11,733 Reduced 9.3%	114,480 $21.1 Million
Q1 2019 Apr 09, 2019	SELL	$180.87 - $203.88 $1.57 Million - $1.76 Million	-8,655 Reduced 6.42%	126,213 $24 Million
Q4 2018 Jan 28, 2019	SELL	$178.4 - $208.25 $1.46 Million - $1.7 Million	-8,180 Reduced 5.72%	134,868 $26.3 Million
Q3 2018 Oct 18, 2018	SELL	$185.29 - $208.89 $2.76 Million - $3.11 Million	-14,877 Reduced 9.42%	143,048 $29.7 Million
Q2 2018 Jul 19, 2018	SELL	$166.05 - $186.51 $4.37 Million - $4.91 Million	-26,331 Reduced 14.29%	157,925 $29.2 Million
Q1 2018 Apr 30, 2018	SELL	$169.43 - $198.0 $5.76 Million - $6.73 Million	-33,968 Reduced 15.57%	184,256 $31.4 Million
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $5.5 Million - $6.14 Million	-32,582 Reduced 12.99%	218,224 $37.9 Million
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $42 Million - $47.9 Million	250,806	250,806 $46.8 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Amgen Inc Transaction History